Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 34.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,630 shares of the company’s stock after selling 7,172 shares during the period. New York State Common Retirement Fund’s holdings in Astrana Health were worth $430,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. State Street Corp bought a new stake in shares of Astrana Health in the third quarter worth $91,966,000. Geode Capital Management LLC bought a new stake in shares of Astrana Health in the 3rd quarter worth about $58,995,000. FMR LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at about $48,413,000. Loomis Sayles & Co. L P acquired a new stake in shares of Astrana Health in the 3rd quarter valued at about $30,251,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in Astrana Health in the third quarter worth about $25,945,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ASTH has been the subject of several research analyst reports. Macquarie raised Astrana Health to a “hold” rating in a report on Monday, December 16th. Bank of America dropped their price target on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a research report on Tuesday. Truist Financial reduced their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Robert W. Baird lowered their target price on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday. Finally, Stifel Nicolaus reduced their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.83.

Astrana Health Stock Performance

ASTH stock opened at $26.78 on Wednesday. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20. The stock has a market capitalization of $1.51 billion, a price-to-earnings ratio of 20.60, a PEG ratio of 1.37 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The stock’s fifty day moving average is $34.70 and its two-hundred day moving average is $44.31.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million during the quarter, compared to the consensus estimate of $617.24 million. On average, research analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.